Quidel Investors

Quidel Corporation is a point-of-care diagnostics company based in San Diego, California, established in 1979 Under the leadership of Douglas C Bryant, the organization has become a leading provider of rapid diagnostic testing solutions and cellular-based virology assays The company specializes in developing, manufacturing, and marketing innovative diagnostic healthcare products for both professional and consumer markets As a publicly-traded company (QDEL), Quidel has established itself as a significant player in the diagnostic testing industry, focusing on delivering accurate, rapid results across multiple testing platforms The companys extensive portfolio includes diagnostic solutions for infectious diseases, womens health, gastrointestinal diseases, and other critical healthcare areas Their commitment to innovation in point-of-care testing has positioned them as a key contributor to advancing diagnostic capabilities in both clinical and home settings Quidels focus on developing reliable, user-friendly diagnostic tools demonstrates their dedication to improving healthcare accessibility and patient outcomes through rapid, accurate testing solutions

Acquisitions Number: 10
Founded Date: 1979
Last Funding Type: Grant
Headquarters: USA
Investors Number: 1
Technology: Biomarkers of Female Reproductive Health
Employee Number: 501-1000
Industry: FemTech
Funding Status: Grant
Investor Type: Family Investment Offices